Applied dna biotherapeutics subsidiary linearx to participate in upcoming mrna industry conferences

Stony brook, ny / accesswire / july 18, 2023 / applied dna sciences, inc. (nasdaq:apdn) ("applied dna"), a leader in pcr-based dna technologies, today announced the participation of linearx, inc., its majority-owned biotherapeutics subsidiary, in upcoming mrna industry conferences in boston: july 26 - 28, the mrna-based therapeutics summit at the boston convention and exhibition center and the westin boston seaport. september 26 - 28, the mrna process development & manufacturing summit at the boston convention and exhibition center.
APDN Ratings Summary
APDN Quant Ranking